Dr. Thomas Morton Amidon, MD

Dr. Amidon practices at Overlake Medical Center in Bellevue, Washington, part of MultiCare Health System.

Dr. Amidon's NPI, 1699736579, was assigned on March 30, 2006. Dr. Amidon graduated from Duke University School Of Medicine in 1986. Dr. Amidon holds Washington license MD00033351.

Dr. Amidon's primary practice is Overlake Medical Center, at 1035-116Th Ave NE, Bellevue, WA 98004 in King County. The practice phone is (425) 688-5000.

Dr. Amidon's primary practice is Overlake Medical Center in Bellevue, Washington, part of MultiCare Health System. Dr. Amidon is also affiliated with EvergreenHealth Medical Center. The medical group on file is Select Rehabilitation. Dmand AI also links Dr. Amidon to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amidon practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Amidon's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Amidon is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Amidon's licenses on file in 3 states: Washington, California and Montana.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Amidon treats.

CMS data shows 2,470 Medicare services from Dr. Amidon across 26 procedure codes in 2024, for 1,100 Medicare patients. Medicare paid $127,984 for them.

CMS counts 1,100 Medicare patients who saw Dr. Amidon in 2024. The largest group is 75 to 84, with 444 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Amidon's median patient age at 67, with 44% women.

In 2024, Dr. Amidon wrote 5,525 Medicare Part D claims for 704 patients. 87% of them were for generic drugs. CMS names the drug for 5,253 of them, across 56 drugs with 11 or more claims each, at $834,710 in total drug cost. In 2023, CMS named 5,375 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Amidon for performance year 2024, reported through an alternative payment model (APM). Dr. Amidon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of coronary angioplasty and stenting by Dr. Amidon, more than 35% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Amidon. The most frequent topics are Coronary Disease, Coronary Vessels and Angioplasty, Balloon, Coronary. Dr. Amidon has published most often in Am Heart J. Dr. Amidon's most frequent co-authors are Tony M. Chou, MD, Paul G. Yock, MD and Vikas Bhushan, MD.

CMS Open Payments shows 289 general payments to Dr. Amidon from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Sanofi and Genzyme US Companies paid the most, $46,767.

Dmand AI lists 4 awards for Dr. Amidon, most recently Regional Top Doctor in 2014.

Dr. Amidon graduated from Duke University School Of Medicine in 1986. Dr. Amidon is a member of ACC.

Dr. Amidon is in network with 8 carriers, including United Healthcare, Excellus BlueCross BlueShield and Humana. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.